Thromb Haemost
DOI: 10.1055/a-2600-6318
Cellular Signaling and Proteolysis

CXCL2 Mediates Lactate Secretion and Promotes Aortic Dissection Formation through the p38/JNK/C-myc Pathways

Jiakang Li*
1   Department of Cardiac Surgery, Fujian Medical University Union Hospital, Fuzhou, China
2   The Key Laboratory of Fujian Province Universities on Ion Channel and Signal Transduction in Cardiovascular Diseases, Department of Pathophysiology, The School of Basic Medical Sciences, Fuzhou, China
3   Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, China
,
Zhihuang Qiu*
1   Department of Cardiac Surgery, Fujian Medical University Union Hospital, Fuzhou, China
3   Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, China
,
Rumei Xie
1   Department of Cardiac Surgery, Fujian Medical University Union Hospital, Fuzhou, China
2   The Key Laboratory of Fujian Province Universities on Ion Channel and Signal Transduction in Cardiovascular Diseases, Department of Pathophysiology, The School of Basic Medical Sciences, Fuzhou, China
3   Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, China
,
Likang Ma
1   Department of Cardiac Surgery, Fujian Medical University Union Hospital, Fuzhou, China
3   Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, China
,
Lele Tang
1   Department of Cardiac Surgery, Fujian Medical University Union Hospital, Fuzhou, China
3   Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, China
,
Mengge Yao
1   Department of Cardiac Surgery, Fujian Medical University Union Hospital, Fuzhou, China
2   The Key Laboratory of Fujian Province Universities on Ion Channel and Signal Transduction in Cardiovascular Diseases, Department of Pathophysiology, The School of Basic Medical Sciences, Fuzhou, China
3   Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, China
,
Zhaofeng Zhang
1   Department of Cardiac Surgery, Fujian Medical University Union Hospital, Fuzhou, China
3   Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, China
,
Liangwan Chen
1   Department of Cardiac Surgery, Fujian Medical University Union Hospital, Fuzhou, China
3   Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, China
,
1   Department of Cardiac Surgery, Fujian Medical University Union Hospital, Fuzhou, China
2   The Key Laboratory of Fujian Province Universities on Ion Channel and Signal Transduction in Cardiovascular Diseases, Department of Pathophysiology, The School of Basic Medical Sciences, Fuzhou, China
3   Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, China
› Author Affiliations
Funding This study was supported by the National Natural Science Foundation of China (U2005202, 82370470, 82241209).


Abstract

Background

Aortic dissection (AD) is a critical cardiovascular condition with high mortality risk, and elevated lactate levels are linked to increased postoperative mortality in AD patients. CXCL2 is recognized for its significant involvement in cardiovascular pathologies. Nevertheless, the mechanisms by which CXCL2 regulates lactate levels in AD remain to be fully elucidated.

Methods

We assessed CXCL2, CXCR2, p38/JNK, C-myc, MCT1, and MCT4 expression using Western blotting, real-time PCR, and immunostaining on AD patient samples, mouse models, and human aortic vascular smooth muscle cells (HAVSMCs). Lactate levels were measured with a lactate assay kit, and we investigated CXCL2's role in AD through vessel incubation.

Results

CXCL2 and CXCR2 expression was significantly upregulated in AD, accompanied by increased lactate secretion. Overexpression of CXCL2 not only stimulated lactate secretion but also expedited AD progression. In contrast, CXCR2 inhibition effectively countered the effects of CXCL2. Furthermore, CXCL2 elevated the expression of MCT1 and MCT4; inhibition of them alleviated CXCL2-induced AD and lactate accumulation. CXCL2 also activated the p38 and JNK signaling pathways and upregulated C-myc expression, leading to enhanced lactate secretion in HAVSMCs. Blocking these pathways reversed the effects induced by CXCL2.

Conclusion

The CXCL2–CXCR2 axis regulated lactate secretion and drove the progression of AD through the activation of the p38/JNK/C-myc signaling pathways. These findings provide new insights into the molecular mechanisms underlying AD and identify potential therapeutic targets for clinical intervention.

Authors' Contribution

J.L. contributed to writing—original draft. R.X., L.M., and L.T. contributed to data analysis. M.Y. and Z.Z. contributed to methodology. Z.Q. contributed to investigation. L.Z. and L.C. contributed to writing—review and editing.


* These authors contributed equally to this study.


Supplementary Material



Publication History

Received: 20 November 2024

Accepted: 05 May 2025

Article published online:
21 May 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 
  • References

  • 1 Hiratzka LF, Bakris GL, Beckman JA. et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, Society for Vascular Medicine. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 2010; 121 (13) e266-e369
  • 2 Wang ZY, Cheng J, Wang Y. et al. Macrophage ILF3 promotes abdominal aortic aneurysm by inducing inflammatory imbalance in male mice. Nat Commun 2024; 15 (01) 7249
  • 3 Wang T, Ye Z, Li Z. et al. Lactate-induced protein lactylation: a bridge between epigenetics and metabolic reprogramming in cancer. Cell Prolif 2023; 56 (10) e13478
  • 4 Pan Q, Xie X, Yuan Q. Monocarboxylate transporter 4 protects against myocardial ischemia/reperfusion injury by inducing oxidative phosphorylation/glycolysis interconversion and inhibiting oxidative stress. Clin Exp Pharmacol Physiol 2023; 50 (12) 954-963
  • 5 Yang L, Gao L, Nickel T. et al. Lactate promotes synthetic phenotype in vascular smooth muscle cells. Circ Res 2017; 121 (11) 1251-1262
  • 6 Bennett JM, Wise ES, Hocking KM, Brophy CM, Eagle SS. Hyperlactemia predicts surgical mortality in patients presenting with acute Stanford type-A aortic dissection. J Cardiothorac Vasc Anesth 2017; 31 (01) 54-60
  • 7 Wang Z, Li K, Xu J, Cheng X, Wang D. Construction of a lactate-related prognostic signature for predicting prognosis after surgical repair for acute type a aortic dissection. Front Physiol 2022; 13: 1008869
  • 8 Wiesner P, Choi SH, Almazan F. et al. Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kappa B and activator protein-1: possible mechanism for acceleration of atherosclerosis by subclinical endotoxemia. Circ Res 2010; 107 (01) 56-65
  • 9 Al-Amran FF, Shahkolahi M. Oxytocin ameliorates the immediate myocardial injury in heart transplant through down regulation of the neutrophil dependent myocardial apoptosis. Heart Views 2014; 15 (02) 37-45
  • 10 Montecucco F, Bauer I, Braunersreuther V. et al. Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction. Antioxid Redox Signal 2013; 18 (06) 630-641
  • 11 Rabinowitz JD, Enerbäck S. Lactate: the ugly duckling of energy metabolism. Nat Metab 2020; 2 (07) 566-571
  • 12 Zhang L, Qiu Z, Zheng H. et al. Single cell RNA sequencing reveals the pathogenesis of aortic dissection caused by hypertension and Marfan syndrome. Front Cell Dev Biol 2022; 10: 880320
  • 13 Zhang R, Dong M, Tu J. et al. PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway. Signal Transduct Target Ther 2023; 8 (01) 97
  • 14 Dorhoi A, Iannaccone M, Farinacci M. et al. MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment. J Clin Invest 2013; 123 (11) 4836-4848
  • 15 Korbecki J, Kojder K, Kapczuk P. et al. The effect of hypoxia on the expression of CXC chemokines and CXC chemokine receptors—a review of literature. Int J Mol Sci 2021; 22 (02) 843
  • 16 Korbecki J, Kupnicka P, Chlubek M, Gorący J, Gutowska I, Baranowska-Bosiacka I. CXCR2 receptor: regulation of expression, signal transduction, and involvement in cancer. Int J Mol Sci 2022; 23 (04) 2168
  • 17 Li W, Hsiao HM, Higashikubo R. et al. Heart-resident CCR2+ macrophages promote neutrophil extravasation through TLR9/MyD88/CXCL5 signaling. JCI Insight 2016; 1 (12) e87315
  • 18 Mai J, Nanayakkara G, Lopez-Pastrana J. et al. Interleukin-17A promotes aortic endothelial cell activation via transcriptionally and post-translationally activating p38 mitogen-activated protein kinase (MAPK) pathway. J Biol Chem 2016; 291 (10) 4939-4954
  • 19 Mager CE, Mormol JM, Shelton ED. et al. p38 MAPK and MKP-1 control the glycolytic program via the bifunctional glycolysis regulator PFKFB3 during sepsis. J Biol Chem 2023; 299 (04) 103043
  • 20 Liberti MV, Locasale JW. The Warburg effect: how does it benefit cancer cells?. Trends Biochem Sci 2016; 41 (03) 211-218
  • 21 Liu W, Wang Y, Bozi LHM. et al. Lactate regulates cell cycle by remodelling the anaphase promoting complex. Nature 2023; 616 (7958) 790-797
  • 22 Shetty V, Shales S, Narayan P. Lactate levels: a reliable tool to predict mortality in acute type A aortic dissections?. J Card Surg 2022; 37 (05) 1212-1214
  • 23 Sonveaux P, Copetti T, De Saedeleer CJ. et al. Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis. PLoS One 2012; 7 (03) e33418
  • 24 Doherty JR, Cleveland JL. Targeting lactate metabolism for cancer therapeutics. J Clin Invest 2013; 123 (09) 3685-3692
  • 25 Dhup S, Dadhich RK, Porporato PE, Sonveaux P. Multiple biological activities of lactic acid in cancer: influences on tumor growth, angiogenesis and metastasis. Curr Pharm Des 2012; 18 (10) 1319-1330
  • 26 Zhu Y, Wu J, Yuan SY. MCT1 and MCT4 expression during myocardial ischemic-reperfusion injury in the isolated rat heart. Cell Physiol Biochem 2013; 32 (03) 663-674
  • 27 Meng Z, Wang Y, Wang X, Han X. TRIB3 promotes the growth of oral squamous cell carcinoma by regulating JNK/JUN-mediated aerobic glycolysis. Arch Oral Biol 2024; 164: 105977
  • 28 Wang Y, Chen L, Zhang M. et al. Exercise-induced endothelial Mecp2 lactylation suppresses atherosclerosis via the Ereg/MAPK signalling pathway. Atherosclerosis 2023; 375: 45-58
  • 29 Doherty JR, Yang C, Scott KE. et al. Blocking lactate export by inhibiting the Myc target MCT1 disables glycolysis and glutathione synthesis. Cancer Res 2014; 74 (03) 908-920
  • 30 Pérez-Escuredo J, Dadhich RK, Dhup S. et al. Lactate promotes glutamine uptake and metabolism in oxidative cancer cells. Cell Cycle 2016; 15 (01) 72-83
  • 31 Roche ME, Ko YH, Domingo-Vidal M. et al. TP53 induced glycolysis and apoptosis regulator and monocarboxylate transporter 4 drive metabolic reprogramming with c-MYC and NFkB activation in breast cancer. Int J Cancer 2023; 153 (09) 1671-1683
  • 32 Green AR, Aleskandarany MA, Agarwal D. et al. MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours. Br J Cancer 2016; 114 (08) 917-928
  • 33 Whitaker-Menezes D, Martinez-Outschoorn UE, Lin Z. et al. Evidence for a stromal-epithelial “lactate shuttle” in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts. Cell Cycle 2011; 10 (11) 1772-1783
  • 34 Pan L, Bai P, Weng X. et al. Legumain is an endogenous modulator of integrin αvβ3 triggering vascular degeneration, dissection, and rupture. Circulation 2022; 145 (09) 659-674